Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ex Vivo Evaluation of ALDH Inhibitor DIMATE in Leukemic Stem Cells
NCT02748850Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jun 2016
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoints: Number of cells in apoptosis at 48 months and Number of cells which shows a rate the ALDH at 48 months. Status: unknown.
Beyond the preview
Go deeper on NCT02748850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748850.